contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Xvivo Perfusion är verksamt inom medicinteknikbranschen och fokuserar på utveckling och tillverkning av system för organtransplantation och perfusion. Exempel på produkter som bolaget levererar innefattar kanyler, organförvaring samt kyllösningar. Bolagets produkter riktar sig till sjukvårdsinstitutioner och kirurger. Xvivo Perfusion är verksamt globalt, grundades 1998 och har sitt huvudkontor i Göteborg.

Xvivo Perfusion

Invitation to attend XVIVO Perfusion’s conference call regarding the presentation of the interim report July – September 2020. The presentation will be held in English.Time: Friday, October ...

<div class="mfn-preamble">Invitation to attend XVIVO Perfusion’s conference call regarding the presentation of the interim report July – September 2020. The presentation will be held in English.</div><div class="mfn-body">Time: Friday, October 23, 2020 at 2.30 p.m. CETInformation regarding the conference can be found under the following link: <a href="https://bluejeans.com/405912591" target="_blank" rel="nofollow noopener">https://bluejeans.com/405912591</a>Phone numbers to the conference: +46.8.5886.8700 (Sweden) +46.850.513.580 (Sweden (Stockholm)) +44.203.608.5256 (UK (London) +1.404.458.0105 (United States) +47.2160.1825 (Norway (Oslo)Global Numbers can be found under the link: https://www.bluejeans.com/numbers Conference name: XVIVO Virtual call, conference ID: 405 912 591#   Participants from XVIVO Perfusion: Dag Andersson, CEO Christoffer Rosenblad, CFO   The telephone conference will be adminsitrated by Ulrik Trattner, Carnegie. To send a question, please email Ulrik.trattner@carnegie.se or use the chat function which you can find in the top right corner of the screen.   The press release for XVIVO Perfusion’s interim report July-September 2020 will be released on October 23, 2020 at 7:30 a.m. CET.   Before the conference call, slides will be available at the company web page, www.xvivoperfusion.com/corporate/.   October 16, 2020 Gothenburg XVIVO Perfusion AB (publ)</div><div class="mfn-footer mfn-contacts">For further information please contact:<hr/>Dag Andersson, CEO, +46 76 643 30 31, e-post: <a href="mailto:dag.andersson@xvivoperfusion.com" target="_blank" rel="nofollow noopener">dag.andersson@xvivoperfusion.com</a> Christoffer Rosenblad, CFO, +46 73 519 21 59 e-post: <a href="mailto:christoffer.rosenblad@xvivoperfusion.com" target="_blank" rel="nofollow noopener">christoffer.rosenblad@xvivoperfusion.com</a></div><div class="mfn-footer mfn-about">About Us<hr/>XVIVO Perfusion AB is a medical technology company which develops solutions and systems for assessing and preserving organs outside the body and for selecting usable organs and maintaining them in optimal condition pending transplantation. The company is headquartered in Gothenburg, Sweden, and has one office in Lund, Sweden, one office in Groningen, the Netherlands and one office in Denver, USA. The XVIVO share is listed on Nasdaq Stockholm and has the ticker symbol XVIVO. More information can be found on the website <a href="http://www.xvivoperfusion.com." target="_blank" rel="nofollow noopener">www.xvivoperfusion.com.</a></div><div class="mfn-footer mfn-attachment mfn-attachment-pdf">Attachments<hr/><a href="https://storage.mfn.se/584678c1-9430-4298-bef1-6e712becf3de/conference-call-on-interim-report.pdf" class="mfn-generated mfn-primary" target="_blank" rel="nofollow noopener">Conference call on Interim Report</a></div>